At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 16 enrolled
Drug / intervention
Pritelivir +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-center, Open-label, 2-period Fixed-sequence Phase I Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Pritelivir
In Brief
A Phase 1 clinical trial evaluating Pritelivir and ESO and pritelivir for HSV Infection. Completed, enrolled 16 participants across 1 site.
Detailed Summary
To investigate the effect of esomeprazole (ESO) on the pharmacokinetics of pritelivir (PTV), and to investigate the safety and tolerability of PTV.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHSV Infection
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
202120222023202420252026
Enrollment StartJul 2020
Primary CompletionOct 2020
First PostedAug 2022
TodayJul 2026
First PostedAug 24, 2022
Enrollment StartJul 13, 2020
Primary CompletionOct 13, 2020
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 3.9 years ago
Interventions
Pritelivirdrug
oral administration
ESO and pritelivirdrug
oral administration